EULAR 2023 Lupus Highlights
Rheumnow Podcast
00:00
Barry Sittenib: A Randomized Control Trial for Non-Renal Lupus
Barry Sittenib is a Jack Inibitter in treating active lupus nephritis. The primary endpoint for this study was reduction of a proteinuria of more than 50% from baseline. There was no significant difference compared to what already known in terms of side effect for Barry Sittenib because the number is quite small.
Play episode from 41:06
Transcript
